Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4880811
SERIAL NO

07066616

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method for decreasing the bodily content of uric acid in a subject which comprises administrating to the subject an effective content-decreasing amount of a barbiturate compound mono-substituted at the carbon-5 position. The invention also provides a pharmaceutical composition and a method for treating disorders of uric acid metabolism and resulting ailments in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES A CORP OF NEW YORK1275 YORK AVENUE NEW YORK NY 10021

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Warrell, Jr Raymond P New York, NY 14 183

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation